QURE - uniQure GAAP EPS of -$2.71 beats by $0.98 revenue of $106.48M beats by $83.27M
- uniQure press release ( NASDAQ: QURE ): FY GAAP EPS of -$2.71 beats by $0.98 .
- Revenue of $106.48M (-79.7% Y/Y) beats by $83.27M .
- As of December 31, 2022, the Company had cash and cash equivalents and investment securities of $392.8 million. The Company expects cash and cash equivalents and investment securities will fund operations into 2025 assuming the achievement of $100.0 million of a first commercial sale milestone for HEMGENIX ® in the U.S. and into the first half of 2025 if the $75.0 million first commercial sale milestone for HEMGENIX ® in any of the five contractually defined European countries is achieved prior to July 2, 2023.
For further details see:
uniQure GAAP EPS of -$2.71 beats by $0.98, revenue of $106.48M beats by $83.27M